Pediatric study bill
Executive Summary
Senate Health Committee adopts Sen. Hillary Clinton's (D-N.Y.) mandatory pediatric research bill Aug. 1 by voice vote. The bill (S 2394) would codify FDA's authority to require pediatric studies from sponsors and award six months exclusivity. Final language does not include an amendment proposed by Sen. Christopher Bond (R-Mo.) that would have awarded three months additional exclusivity for a second round of pediatric studies (1"The Pink Sheet" July 29, p. 11)...
You may also be interested in...
Pediatric Exclusivity Expansion Floated On Hill; Mandatory Study Bill Pending
An additional three months of exclusivity would be awarded for a company's second round of pediatric studies under a proposed amendment to Sen. Hillary Rodham Clinton's (D-N.Y.) bill to codify FDA's mandatory pediatric study rule
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.